SCHEMBL7863259

SCHEMBL7863259

CCC(CC(=O)O)c1cccc(NS(=O)(=O)c2cccc(NC(=N)N)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.46
CA1 P00915 7/20 0.45
CA2 P00918 7/20 0.45
F2 P00734 1/20 0.44
F10 P00742 1/20 0.44
PRSS1 P07477 1/20 0.44
ITGB3 P05106 1/20 0.43
ITGAV P06756 1/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13715863 0.89 PKM (0.46) PKMCA1CA2F2F10
SCHEMBL7856452 0.87 PKM (0.43) PKMCA1CA2F2F10
SCHEMBL7856455 0.87 PKM (0.43) PKMCA1CA2F2F10
SCHEMBL7862046 0.86 ITGB3 (0.45) PKMCA1CA2F2F10
SCHEMBL7864636 0.86 PKM (0.41) PKMCA1CA2F2F10
SCHEMBL7191727 0.83 ITGB3 (0.46) PKMCA1CA2F2F10
SCHEMBL6366667 0.82 ITGB3 (0.60) PKMCA1CA2ITGB3ITGAV
SCHEMBL7788773 0.82 ITGB3 (0.42) PKMCA1CA2F2F10
SCHEMBL7856528 0.82 MEN1 (0.43) PKMCA1CA2ITGB3ITGAV
SCHEMBL7863164 0.82 MEN1 (0.43) PKMCA1CA2ITGB3ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889877-B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS SEARLE & CO (US) 2001-08-29 EP claimed
EP-0889877-B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS SEARLE & CO (US) 2001-08-29 EP disclosed